echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > 21 pharmaceutical enterprises are recognized as the 26th batch of national enterprise technology centers

    21 pharmaceutical enterprises are recognized as the 26th batch of national enterprise technology centers

    • Last Update: 2020-01-15
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    [pharmaceutical network industry trends] looking back to 2019, China's pharmaceutical industry has made a lot of "moves", many of which have the innovative strength of pharmaceutical enterprises to overcome the technical difficulties and achieve overtaking in the corner The author understands that in the list of national enterprise technology centers to be identified and publicized in 2019 (the 26th batch) recently released, a total of 154 national enterprise technology centers and 97 sub centers are to be identified Among the pharmaceutical industry, 20 enterprise technology centers and 1 sub center, including Qianjin pharmaceutical, Yangzi River, Pianzihuang, Yuandong biological, Wuzhou pharmaceutical, Yuanda pharmaceutical and guangshengtang pharmaceutical, were selected, with a total of 21 enterprises The national enterprise technology center is a technology R & D and innovation institution established by enterprises according to the needs of market competition, which is organized and evaluated by the national development and Reform Commission every year The evaluation procedures are strict, and the evaluation standards include economic and technological strength, economic benefits, industry advantages, technological competitive advantages, R & D test conditions, etc., especially whether the enterprise has independent intellectual property rights, core technology, etc It can be seen that the enterprises that can be recognized represent the historic breakthrough in the field of R & D, fully reflecting the influence of their technological innovation ability in the industry According to the relevant provisions of the state, enterprises recognized as national enterprise technology centers can enjoy preferential tax policies to support scientific and technological innovation It is understood that according to the announcement of Qianjin pharmaceutical on the evening of January 13, the company's technology center was recognized as the national enterprise technology center At present, Qianjin Pharmaceutical Co., Ltd has engineering technology research centers such as Hunan Women's health medicine and Hunan traditional Chinese medicine derivatives In 2018, Qianjin pharmaceutical established Qianjin Research Institute, following the guiding ideology of "facing the market, tracking the frontier, integrating resources, and opening up cooperation", the R & D system is becoming more and more perfect, and research results are stably produced, bringing growth to Qianjin pharmaceutical's performance In addition, on January 14, Zhongheng group issued the notice on Issuing the list of newly identified and all national enterprise technology centers in 2019 (the 26th batch), and its holding subsidiary, Wuzhou Pharmaceutical Technology Center, was identified as the national enterprise technology center in 2019 (the 26th batch) As mentioned in the announcement, Wuzhou pharmaceutical technology center is recognized as a national enterprise technology center, which fully affirms the technological innovation ability and independent R & D ability of Wuzhou pharmaceutical, reflects the comprehensive ability of Wuzhou pharmaceutical, and is conducive to further improving the independent innovation ability of Wuzhou pharmaceutical and consolidating the core competitiveness of the company The company will give full play to the positive role of national enterprise technology center in the development of the company Zhongheng group said that the recognition of the national enterprise technology center had a positive effect on the future development of the company and Wuzhou pharmaceutical, but had no significant impact on the company's business performance this year In the first three quarters of 2019, Zhongheng group achieved an operating revenue of 2.752 billion yuan, an increase of 11.77% over the same period of last year; and realized a net profit of 482 million yuan, excluding non recurring profit and loss, attributable to shareholders of listed companies, an increase of 21.36% over the same period of last year Among them, the revenue and profit of Wuzhou pharmaceutical kept a good level of development Recently, Zhuhai Rundu Pharmaceutical Co., Ltd also released a notice that the company's technology center was recognized as the national enterprise technology center The company said that on the basis of being recognized as the "national enterprise technology center", it will continue to optimize innovation construction, make full use of the platform advantages of the "national enterprise technology center", drive the rapid development of enterprises with innovation, further enhance the comprehensive competitiveness of enterprises, and promote the sustainable and healthy development of the company Financial data shows that in 2019, the production and operation of Rundu pharmaceutical has achieved good results, with continuous growth in sales revenue and further enhanced profitability During the reporting period, the operating revenue reached 1.4 billion yuan, an increase of 29.86% over the same period of last year, mainly due to the increase of sales volume of the company's main products.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.